Fgf3 and Fgf8 are required together for formation of the otic placode and vesicle by Maroon, Habib et al.
INTRODUCTION
The otic placode arises as an ectodermal thickening adjacent
to the posterior hindbrain in all vertebrates. It invaginates and
pinches off from the ectoderm to form the otic vesicle, which
subsequently gives rise to the sensory structures of the inner
ear and neurones of the vestibuloacoustic ganglion. Thus, it has
been central to the development of balance, coordination and,
later, hearing during vertebrate evolution and there has been
considerable interest in its embryonic origin.
Experimental studies of the tissue interactions involved in
induction and development of the otic placode span much of
the last century and include contributions from such luminaries
as Yntema (Yntema, 1933), Harrison (Harrison, 1935),
Waddington (Waddington, 1937) and Zwilling (Zwilling,
1941) working on amphibian and avian embryos. These and
the many subsequent studies have implicated two tissues either
acting alone or in combination in the induction of the otic
placode: the underlying mesoderm and the adjacent hindbrain.
The most generally accepted model is that the surface ectoderm
receives an inductive signal from the underlying head
mesoderm that renders it competent to form an otic placode. A
second signal from the posterior hindbrain is then believed to
induce the otic placode and determine its location (for reviews,
see Fritsch et al., 1998; Torres and Giraldez, 1998). However,
the experimental data upon which this hypothesis is based are
inconclusive. 
A search for the molecular players that regulate development
of the otic placode has strongly implicated the fibroblast
growth factors (Fgfs). For example, Fgf3 was first detected in
rhombomeres (r) 5 and 6 of the mouse hindbrain, adjacent to
the developing otic placode (Wilkinson et al., 1988). These
expression studies were extended by Mahmood et al.
(Mahmood et al., 1995a; Mahmood et al., 1996) who reported
expression additionally in r4 of the mouse and in r4, 5 and 6
in the chick embryo. However, various attempts to determine
Fgf3 function in otic development of these embryos have
provided conflicting information. Targeted disruption of the
Fgf3 gene in transgenic mice results in a relatively mild otic
phenotype, defective formation of the endolymphatic duct,
and then only with incomplete penetrance and expressivity
(Mansour et al., 1992). By contrast, application of antisense
oligonucleotides to chick embryos resulted in an invagination
defect (Represa et al., 1991) while ectopic expression of Fgf3
in cranial ectoderm using a viral vector resulted in the
formation of ectopic vesicles expressing some otic markers
(Vendrell et al., 2000).
Several years ago, we reported the cloning of zebrafish fgf3
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Fgf3 has long been implicated in otic placode induction and
early development of the otocyst; however, the results of
experiments in mouse and chick embryos to determine its
function have proved to be conflicting. In this study, we
determined fgf3 expression in relation to otic development
in the zebrafish and used antisense morpholino
oligonucleotides to inhibit Fgf3 translation. Successful
knockdown of Fgf3 protein was demonstrated and this
resulted in a reduction of otocyst size together with
reduction in expression of early markers of the otic
placode. 
fgf3 is co-expressed with fgf8 in the hindbrain prior to
otic induction and, strikingly, when Fgf3 morpholinos were
co-injected together with Fgf8 morpholinos, a significant
number of embryos failed to form otocysts. These effects
were made manifest at early stages of otic development by
an absence of early placode markers (pax2.1 and dlx3)
but were not accompanied by effects on cell division or
death. The temporal requirement for Fgf signalling was
established as being between 60% epiboly and tailbud
stages using the Fgf receptor inhibitor SU5402. However,
the earliest molecular event in induction of the otic
territory, pax8 expression, did not require Fgf signalling,
indicating an inductive event upstream of signalling by
Fgf3 and Fgf8. We propose that Fgf3 and Fgf8 are required
together for formation of the otic placode and act during
the earliest stages of its induction.
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and also determined the biological properties of its protein
product including its receptor specificity (Kiefer et al., 1996a;
Kiefer et al., 1996b). However, we were unable to determine
its developmental role(s) in zebrafish, because of the lack of a
means of inhibiting its function. Recently, chemically modified
oligonucleotides called morpholinos have been used to
specifically inhibit gene function in amphibian and zebrafish
embryos (Heasman et al., 2000; Nasevicius and Ekker, 2000)
and this approach potentially allows targeted ‘knockdown’ of
multiple genes in a single embryo. Morpholinos function by
binding to and inhibiting translation of mRNA and are resistant
to degradation. This development has allowed us to assess Fgf3
function in zebrafish otic development. We show that embryos
with reduced levels of Fgf3 have smaller otic placodes and
vesicles, a similar phenotype to that reported in the ace
zebrafish which is mutated in the fgf8 gene (Reifers et al.,
1998). Moreover, when we co-inject morpholinos targeted
against both fgf3 and fgf8, a significant proportion of embryos
fail to develop otic placodes.
MATERIALS AND METHODS
Fish strains, microinjection of oligonucleotides and
incubation with Fgfr inhibitors
Zebrafish, Danio rerio, of the King’s wild type (kwt) strain were used
throughout these studies. They were maintained at 28 ° C and embryos
staged according to Kimmel et al. (Kimmel et al., 1995). Morpholino
oligonucleotides (GeneTools) were dissolved in distilled water at a
concentration of 20 m g/m l and diluted to 1.5 m g/m l in 120 mM KCl,
20 mM Hepes pH 7.5, 0.25% (w/v) Phenol Red prior to injection.
Oligonucleotides were injected in a volume of 5 nl (containing 7.5ng
of each oligonucleotide) into the yolk cell of one-to eight-cell
embryos just beneath the animal cell(s) as described (Holder and Xu,
1999). 
Oligonucleotide sequences were as follows (bold letters indicate
nucleotide substitutions in control sequences):
Fgf3 morpholino, 5¢ -CATTGTGGCATGGCGGGATGTCGGC-3 ¢;
Fgf3 control morpholino, 5 ¢ -CATTATGTCATGGCGGGAGGT-
GGGC-3¢;
Fgf8 morpholino, 5¢ -GAGTCTCATGTTTATAGCCTCAGTA-3¢ ;
and
Fgf8 control morpholino, 5 ¢ -GAGTATCAGGTTTATAGACTAA-
GTA-3 ¢ .
After injection, embryos were collected in aquarium water
containing methylene blue (Westerfield, 1995) and grown at 28 ° C in
Petri dishes to the desired developmental stages.
For incubation with the Fgfr inhibitor, SU5402 (Calbiochem),
embryos were dechorionated by incubation in 1 mg/ml pronase
(Sigma) in aquarium water for 7 minutes. Chorions were removed by
gently swirling the embryos in several changes of aquarium water,
which also served to remove the pronse by serial dilution. Embryos
were allowed to develop in petri dishes with a layer of 1% agarose on
their base in aquarium water containing methylene blue. Upon
reaching the desired stage, they were incubated in 60 m M SU5402
diluted in aquarium water from a 500 · stock solution dissolved in
DMSO. Control embryos had an equivalent volume of DMSO added
to the aquarium water. Following incubation, embryos were washed
gently in several changes of aquarium water and then grown to the
desired developmental stages. 
In situ hybridisation
Embryos were dechorionated as above. In situ hybridisation using
NBT/BCIP and Fast Red substrates was performed as described
(Shamim et al., 1999; Irving and Mason, 2001). For colour reactions
using p-iodonitrotetrazolium violet (Sigma) as the second substrate
embryos were incubated in 0.188 mg/ml 5-bromo-4-chloro-3-indolyl-
phosphate and 0.2 mg/ml p-iodonitrotetrazolium violet (Liang et al.,
2000).
Zebrafish Fgf3 protein, anti-Fgf3 serum and western blots
Production of zebrafish Fgf3 protein and the monoclonal antibody,
MSD-1, against Fgf3 have been described previously (Mathieu et al.,
1995a; Mathieu et al., 1995b; Kiefer et al., 1996b). SDS PAGE and
immunoblotting techniques were modified from those of Jackson and
Dickson (Jackson and Dickson, 1999). Dechorionated embryos were
extracted in sample buffer (4% w/v SDS, 10% v/v 2-mercaptoethanol,
20% v/v glycerol, 0.125M Tris.HCl pH 6.8, Bromophenol Blue) using
at least 5 m l per embryo. Extracts were immediately heated at 100 ° C
for 5 minutes, centrifuged and stored at –80 ° C. Proteins were
separated on 12% Laemmli SDS-PAGE gels at 150 V alongside
molecular weight markers (BioRad). Gels were briefly equilibrated in
25 mM Tris, 190 mM glycine, 20% v/v methanol prior to
electroblotting onto Immobilon P (Millipore) membranes at 110 V for
1.5-2 hours with cooling. Membranes were briefly dried at room
temperature, rewet in TBS, 1% Tween-20 for 30 minutes, washed
once in TBS, 0.1% Tween-20 and nonspecific binding sites were
blocked in TBS, 0.1% Tween-20, 5% w/v non-fat dried milk (Marvel)
for 2 hours at room temperature or at 4 ° C overnight. Filters were
washed twice each for 5 minutes in TBS, 0.05% Tween-20 before
incubation in MSD-1 diluted 1/1000 in TBS, 1% w/v milk for 2 hours
at room temperature on a rocking platform. Filters were washed three
times in TBS, 0.05% Tween-20 and incubated for 1 hour in 1/20,000
dilution of goat anti-mouse IgG coupled to horseradish peroxidase in
TBS, 1% milk with rocking. Blots were then washed three times in
TBS, 0.05% Tween-20 and excess wash buffer drained onto paper
towels after the final wash. Filters were placed protein side uppermost
on Saranwrap and 0.1 ml/cm2 of lumigen solution (ECL kit,
Amersham-Pharmacia) applied for 5 minutes. Excess lumigen
solution was drained from the filters, which were wrapped in
Saranwrap and exposed to x-ray film (X-Omat-AR, Kodak).
Detection of cell death and proliferation
Dividing cells were detected using an anti-phosphorylated histone H3
(Ser 128) antiserum (Calbiochem) according to the method of Saka
and Smith (Saka and Smith, 2001). Embryos were dechorionated as
above and fixed overnight in 4% (w/v) paraformaldehyde at 4° C. They
were transferred to 100% methanol and stored at –20 ° C. Embryos
were rehydrated through a graded series (75%, 50% and 25%) of
methanol in PBS and then washed twice in PBS before being bleached
for 1 hour in 1% v/v H2O2, 5% v/v formamide, 0.5 · SSC for 30
minutes. They were rinsed with PBS and then with PBSBT [0.2%
BSA (fraction V, Sigma), 0.1% v/v Triton X-100 in PBS] and
incubated in 10% v/v goat serum in PBSBT for 1 hour. Embryos were
then incubated in 1/1000 dilution of anti-phosphorylated histone H3
antiserum overnight at 4 ° C. They were washed briefly in 10% serum
in PBSBT, washed four times each for 1 hour in PBSBT, and then for
an hour in 10% goat serum in PBSBT before incubation in 1/250
dilution of anti-rabbit IgG conjugated to horseradish peroxidase
(Amersham-Pharmacia) overnight at 4° C. After a brief wash in 10%
serum in PBSBT and four washes each for 1 hour in PBSBT, embryos
were equilibrated in 0.3 mg/ml DAB in PBS for 10 minutes and then
H2O2 was added to 0.03% v/v final. Colour reaction was allowed to
develop for 15-30 minutes before being stopped by several rinses with
water, then in PBS. Embryos were cleared in 90% glycerol, PBS.
Apoptotic cells were detected using the DeadEndTM colourimetric
detection kit (Promega). Embryos were dechorionated and fixed
overnight in 4% w/v paraformaldehyde in PBS. They were then
incubated in methanol for 30 minutes and rehydrated through a graded
series of methanol (75%, 50%, 25%) in PBST (PBS, 0.1% Tween-
20), washed twice in PBST and twice in PBS. They were incubated
in proteinase K (5 m g/ml in PBS) for exactly 5 minutes, washed in
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PBS and post-fixed in 4% w/v paraformaldhyde in PBS for 20
minutes. The embryos were then washed three times in PBS and three
times in acetone, being stored at –20 ° C for 10 minutes in the final
acetone wash. They were rinsed three times in PBS before being
incubated for 10 minutes with equilibration buffer (DeadEnd kit). The
equilibration buffer was removed and replaced with the terminal
transferase reaction mix containing biotinylated UTP (DeadEnd kit)
and the reaction was incubated at 37 ° C for 3 hours. Embryos were
washed in 2 · SSC for 30 minutes, three times in PBST and three times
in PBS before being incubated in streptavidin-HRP 1/500 in PBS for
1 hour. After three washes in PBS, the colour reaction was performed
using the DAB substrate and reaction mix provided with the kit. The
reaction was stopped with several washes in distilled water, then in
PBS and embryos were cleared in 90% glycerol, PBS.
RESULTS
fgf3 expression in relation to otic placode and
otocyst development
We determined the distribution of fgf3 transcripts during the
period of otic placode induction and otocyst formation in the
zebrafish embryo. fgf3 mRNA is first detected by in situ
hybridisation in the neural plate adjacent to the prospective otic
territory at 90% epiboly (Fig. 1A). At this and later stages it is
also expressed in other tissues, e.g. forebrain and tailbud (Fig.
1A-H) (J. W., H. M., R. M. and I. M.,
unpublished). The initial domain of
expression in the hindbrain is quite broad
(Fig. 1A,B) but rapidly refines to a single
rhombomere by early somite (s) stages
(Fig. 1C-E). It is downregulated at 20
somites (19 hours; Fig. 1F) and is
undetectable in the hindbrain by 26
somites (22 hours; data not shown).
To determine the precise location of
fgf3 mRNA in the hindbrain, hybridisation
was performed with a probe for krox20
expressed in r3 and r5 (Oxtoby and
Jowett, 1993). The domain of fgf3 was
always flanked by the krox20-positive
territories. At early somite stages, before
rhombomeric domains are segregated,
there appeared to be some overlap in
expression at the anterior and posterior
boundaries of the fgf3-positive territory
(Fig. 1G). However, fgf3 transcripts
eventually became confined to r4 (Fig.
1H) and were never detected in r5 or r6 as
observed in mouse and chick embryos
(Wilkinson et al., 1988; Mahmood et al.,
1995a; Mahmood et al., 1996).
Expression initially spanned the
mediolateral extent of the neural plate
(Fig. 1D) and after neurulation occupied
the entire dorsoventral extent of r4 at early
neural tube stages (Fig. 1E,G). However,
by 14 somites (16 hours), expression was
confined to ventral r4 (compare Fig. 1H
with 1I and see Fig. 1F).
As is the case in avian embryos (Groves
and Bronner-Fraser, 2000), the
morphological manifestation of the zebrafish otic placode is
presaged by the expression of transcripts of a number of genes.
dlx3, which is initially expressed at the neurectoderm-ectoderm
interface of the cranial neural plate, becomes upregulated in
the prospective otic territory by bud stages (10 hours) and then
becomes restricted to the otic placode (Ellies et al., 1997;
Mendonsa and Riley, 1999). pax8 is expressed in ectoderm in
the region of the prospective otic placode from bud stages (10
hours) and expression is confined to the otic placode when the
latter becomes visible morphologically. Two other members of
the Pax family, pax2.1 and pax2.2, are expressed in a similar
manner in the prospective otic territory from two somites and
three somites, respectively (Pfeffer et al., 1998). Thereafter, the
placode can be distinguished using Normarski optics from 9
somites, invaginates to form a vesicle by 19 somites and
otoliths are visible from 25 hours (prim 7) (Kimmel et al.,
1995). Thus, our study indicates that the onset of fgf3
expression precedes that of the first molecular markers of
prospective otic ectoderm. 
We have compared the spatial relationship of fgf3
transcripts with three of these markers, dlx3, pax2.1 and pax8,
at early stages of otic placode development. dlx3 expression
is detected adjacent to the r4 fgf3 expression domain and
extends approximately two rhombomere lengths posterior to
r4 (Fig. 1J,K). The pax2.1 and pax8 domains also lie adjacent
Fig. 1. fgf3 expression in relation to
otic placode and otocyst development.
(A-H,J-L) Detection of fgf3 mRNA in
the developing hindbrain (arrows) of
the zebrafish embryo. (A) 90% epiboly.
(B) Bud (10 hours). (C) 5 somites
(11.75 hours). (D) Flatmount of a 5
somite (11.75 hours) embryo; anterior towards the left. (E) 14 somite (16 hours). (F) 20
somites (19 hours). (G,H) Hybridisation to fgf3 (blue) and krox20 (red) in 4 somite (G) and
14 somite (H) embryos. (I) Detection of hoxb1 (blue) and krox20 (red) in a 12 somite
embryo. (J,K) fgf3 (blue) and dlx3 (orange) expression in 3 somite embryos; (K)
flatmount. (L) Flatmount showing fgf3 (blue) and pax2.1 (orange) in a 5 somite embryo.
(M) Flatmounted 10 somite embryo showing fgf3 (orange) and pax8 (blue). (N) Dorsal
view of an embryo at 90% epiboly to show onset of fgf8 expression (arrowhead) in the
presumptive r4 territory.
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to r4 but extends both anteriorly, adjacent to r3, and
posteriorly, adjacent to r5 and r6 (Fig. 1L,M), and thus may
define a region of otic competence rather than the presumptive
placode itself.
Transcripts of a second member of the Fgf family, fgf8
which signals from the isthmus to pattern midbrain and
anterior hindbrain (Reifers et al., 1998), was also found to
be expressed in the presumptive r4 territory at 90% epiboly
prior to its expression in the isthmus (midbrain-hindbrain
junction; Fig. 1N) (Phillips et al., 2001) (J. W., H. M. and
I. M., unpublished). Thus, at least two Fgfs are expressed
in the hindbrain adjacent to the presumptive otic territory
before the first molecular markers of the specification of the
latter. 
Inhibition of Fgf3 and Fgf8 together results in
absence of the otic vesicle
To investigate Fgf3 function in the zebrafish
embryo, we used morpholino oligonucleotides
(Nasevicius and Ekker, 2000) injected into one-
to eight-cell stage embryos to inhibit translation
of Fgf3 protein. Zebrafish Fgf3 is a protein with
an Mr of about 28,000 when detected on
immunoblots (Fig. 2A). Fgf3 protein in blots of
total protein extracts from individual embryos
that had been injected with Fgf3 morpholino
(Fgf3mo) was either greatly reduced or
undetectable when compared with either wild-
type fish or fish injected with a control
morpholino which differed by only four
nucleotides from the Fgf3mo (Fig. 2B) (J. W., H.
M. and I. M. submitted and data not shown). The
level of repression of translation varied between
different Fgf3mo-injected embryos and thus it
was expected that a hypomorphic series would
be generated as previously reported by others
(Nasevicius and Ekker, 2000). In addition, using
a morpholino against fgf8 (Fgf8mo), we were
also able to phenocopy the homozygous ace
zebrafish mutant which is mutated in the fgf8
gene. Defects observed in these embryos
included loss of cerebellar tissue (Fig. 2C,D), somite defects
(data not shown) and reduction in otocyst size. All of these
defects were previously reported in homozygous ace fish
(Reifers et al., 1998).
Embryos injected with Fgf3mo were allowed to develop to
26 hours (prim8) and their otocysts were examined under
Normarski optics. While otocysts were present in all cases and
these generally had two otoliths, a large number of embryos
exhibited a reduction in otocyst size of about 30-35% (Fig.
3A,B; Table 1). This phenotype was remarkably similar to that
reported for homozygous ace/fgf8 mutant fish. fgf8 is
expressed initially in the presumptive r4 territory, although at
later stages its domain of expression extends from the isthmus
to r4 prior to becoming restricted to the isthmus (Reifers et al.,
1998) (data not shown). Consistent with the study of Reifers
et al. (Reifers et al., 1998), we saw similar reductions in otocyst
size after Fgf8mo injections (Fig. 3C), indeed the resultant
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Fig. 2. Inhibition of Fgf3 and Fgf8 using morpholinos. (A) Immunoblot detection of Fgf3 in extracts of zebrafish embryos probed with an anti-
Fgf3 antibody. Lane 1: zebrafish Fgf3 produced in and purified from a mammalian cell line. Lane 2: Recognition of zebrafish Fgf3 in an extract
of four 5 somite embryos. The other crossreacting bands were detected variably from blot to blot and were not sensitive to knockdown by
Fgf3mo. (B) Reduction in Fgf3 protein in immunoblots of individual Fgf3mo-injected embryos. Lanes 1-4: detection of Fgf3 in protein extracts
of individual 5 somite embryos. Lane 1: uninjected embryo. Lane 2: embryo injected with control Fgf3 morpholino. Lanes 3 and 4: embryos
injected with Fgf3mo. (C,D) Fgf8mo phenocopies homozygous ace zebrafish at 26 hours of development. (C) Embryo injected with control
Fgf8 morpholino. (D) Embryo injected with Fgf8mo lacks cerebellar tissue. Te, telencephalon; Cb, cerebellum.
Fig. 3. Size reduction and loss of otic vesicles in fish injected with Fgf3 and Fgf8
morpholinos. (A-E) 26 hour (prim 8) embryos photographed at the same
magnification using Nomarski optics. Where otic vesicles are present (arrows),
their maximum diameter (anteroposterior axis) is measured and indicated in red.
(A) Embryo injected with control Fgf3 morpholino. (B) Embryo injected with
Fgf3mo. (C) Embryo injected with Fgf8mo. (D,E) Embryos co-injected with
Fgf3mo and Fgf8mo showing further reduced size (D) or absence of an otocyst
(E).
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otocysts were slightly smaller than those obtained following
Fgf3mo injections (Table 1).
These data, together with the co-expression of both fgf3 and
fgf8 in r4, prompted us to inject simultaneously morpholinos
against both into embryos. After such injections, we obtained
a range of phenotypes consistent with our predictions of
generation of a hypomorphic series and with the likelihood of
mosaic uptake of the morpholinos (Table 1). Embryos were
mostly more severely affected by co-injection of Fgf3mo and
Fgf8mo than by injection of each alone. Phenotypes ranged
from otocysts that were even smaller than those observed after
injection of single morpholinos and which lacked otoliths, to
complete absence of otic vesicles (Fig. 3D,E; Table 1). The
complete absence of an otic vesicle correlated well with
absence of cerebellar tissue (predicted from loss of Fgf8
function) and defects in the production of the most posterior
somites (caudal to somite 23) in the same embryos. The latter
phenotype was seen in embryos injected with Fgf3mo alone,
consistent with tail defects observed in mice homozygous null
for fgf3 (Mansour et al., 1992) (J. W., H. M., R. M. and I. M.,
unpublished). The tail defect was never seen in Fgf8mo-
injected embryos. Thus, absence of an otocyst was detected in
embryos in which gene knock-down appeared to have been
achieved most efficiently.
Cell death and division are unaffected by inhibition
of Fgf3 and Fgf8
The effects of Fgf3 and Fgf8 morpholinos on otic development
might be due to influences on cell death or proliferation in the
otic territory. We examined injected embryos for effects on
apoptosis using the TUNEL procedure
at the time of morphological appearance
of the otic vesicle. Apoptotic cells were
only infrequently detected in embryos
injected with control morpholinos (Fig.
4A,B; n=28), Fgf3 morpholinos (Fig.
4C,D; n=33) or Fgf8 morpholinos (Fig.
4E,F; n=23). By contrast, many more
apoptotic cells were detected in embryos
Table 1. Effects of Fgf3 and Fgf8 morpholinos (mo) on early and late otic development
Control Fgf3mo Fgf8mo Fgf3mo + Fgf8mo
Small otic vesicle (26 hours) 0/57 31/54 38/58 40/116
Maximum vesicle diameter
in affected embryos 128±7 m m 93±8 m m 79±5 m m 52±12 m m
Absence of otic vesicle (26 hours) 0/57 0/54 0/58 52/116
Reduced dlx3 0/28 46/58 66/80 13/56
Loss of dlx3 0/28 0/58 0/80 35/56
Reduced pax2.1 0/48 32/41 12/20 12/48
Loss of pax2.1 0/48 0/41 0/20 27/48
Reduced pax8 0/40 0/37 0/44 12/23
Loss of pax8 0/40 0/37 0/44 1/23
Fig. 4. Detection of apoptotic and dividing
cells in embryos injected with Fgf3 and
Fgf8 morpholinos. Apoptotic (A-L) and
dividing cells (M-T) detected in lateral
views of zebrafish embryos at 14 somites
photographed at low and high magnification
(A-H) and in dorsal views of the hindbrain
and otic territory of embryos at 8 somites (I-
T). (A,B,I) Embryos injected with control
Fgf3 morpholino. (C,D,K) Embryos
injected with Fgf3 morpholino.
(E,F,J) Embryos injected with Fgf8
morpholino. (G,H,L) Embryos injected with
both Fgf3 and Fgf8 morpholinos; note large
number of apoptotic cells in the dorsal
midline of the neural tube in 14 somite
embryos. (M-T) Low magnification
(M,O,Q,S) and high magnification
(N,P,R,T) views of dividing cells in the
hindbrains and adjacent otic territory of
embryos injected with both control
morpholinos together (M,N), Fgf3
morpholino (O,P), Fgf8 morpholino
(Q,R) and Fgf3mo together with Fgf8mo
(S,T).
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injected with Fgf3 and Fgf8 morpholinos in combination (Fig.
4G,H; n=46). However these dying cells were localised
primarily to the dorsal neural tube region throughout its length
(Fig. 4G) and the prospective otic ectoderm adjacent to the
hindbrain showed no increase in numbers of apoptotic cells
(Fig. 4H). We also examined embryos at the 8-somite stage,
prior to appearance of the otic placode but when molecular
markers suggest that the otic ectoderm has been specified. We
found very few apoptotic cells either in control embryos or
those that had been injected with morpholinos (Fig. 4I-L)
We also used an antibody against phosphorylated (Ser28)
histone H3 to detect mitotic cells between G2 and telophase
(Saka and Smith, 2001). Numerous dividing cells were
observed but no differences in numbers of cells in mitosis were
found in ectoderm adjacent to the hindbrain in embryos
injected with morpholinos either singly or in combination
when compared with control embryos (Fig. 4M-T).
Early defects in otic development of Fgf3 and Fgf8
knockdown zebrafish
The early onset of fgf3 and fgf8 expression adjacent to the
presumptive otic territory, together with the lack of obvious
effects on cell death after morpholino injections, suggested that
the absence or reduced size of otic vesicles might be due to
defects in induction of the otic ectoderm. To determine whether
or not Fgf3 and Fgf8 are required at the earliest stages of otic
placode development, we examined expression of two early
placode markers, dlx3 and pax2.1, in embryos injected with
Fgf3mo and Fgf8mo singly and in combination. We found that
neither Fgf3 or Fgf8 morpholinos injected alone prevented
early or late expression of otic dlx3 and pax2.1 (Fig.
5B,C,F,G,J,K,N,O). However, expression was both weaker and
less extensive along the anteroposterior axis than observed in
control embryos (compare with Fig. 5A,E,I,M; Table 1). Other
sites of expression were also affected, for example isthmic
pax2.1 is lost in Fgf8mo-injected fish as
expected from previous studies (Reifers et
al., 1998).
In contrast to effects of the individual
morpholinos, when both Fgf3mo and
Fgf8mo were co-injected a significant
number of embryos lacked either early or
late expression of dlx3 and pax2.1 (Fig.
5D,H,L,P; Table 1). Others showed reduced expression similar
to that observed in injections of single oligonucleotides and
consistent with predictions of a hypomorphic series expressing
varying levels of protein being generated (data not shown).
Taken together, these data suggest that Fgf3 and Fgf8 are
required at the earliest stages of otic placode induction and/or
specification.
Inhibition of Fgf signalling confirms its requirement
during early otic development
To confirm our findings and to investigate the temporal
requirement for Fgf signalling further, we incubated embryos,
denuded of their chorions, in SU5402, a widely used inhibitor
of Fgf receptor (Fgfr) activation. Predictions based upon
structures of co-crystals of Fgf receptor tyrosine kinase domain
and SU5402 suggest that it should block kinase activity and
therefore signalling by all Fgf receptors (Mohammadi et al.,
1997). Embryos were incubated in inhibitor for 5 hours starting
at 30% epiboly, 60% epiboly and 5-somite stages, reaching
tailbud, 2- to 3-somite and 16-somite stages, respectively, at
the end of the incubation period. To demonstrate the
effectiveness of the treatment, a subset of the embryos were
fixed immediately and processed for in situ hybridisation for
transcripts of the Ets family transcription factor, erm. Erm is a
member of a subfamily of Ets proteins that are transcriptionally
activated by activated Erk1 and Erk2 (MAP kinases), which
themselves are activated following Fgfr activation. Distribution
of activated Erk protein is identical to erm mRNA distribution
during early zebrafish development (J. W. and I. M.,
unpublished) and closely parallels distribution of fgf3 and fgf8
transcripts. Moreover, treatment with SU5402 abrogates erm
expression (Raible and Brand, 2001; Roehl and Nusslein-
Volhard, 2001). 
erm transcripts were either absent or barely detectable in the
otic region and hindbrain of all embryos at the end of
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Fig. 5. Loss of early otic placode markers in
embryos injected with Fgf3 and Fgf8
morpholinos. Embryos were hybridised for dlx3
(A-H) and pax2.1 (I-P) after incubation to 2-5
somite (A-D and I-L) or 18-21 somite (E-H and
M-P) stages after injection with morpholinos.
(A,E,I,M) Embryos injected with control Fgf3
morpholino are indistinguishable from
uninjected embryos. (B,F,J,N) Embryos injected
with Fgf3mo show reduction in level and extent
of dlx3 (B,F) and pax2.1 (J,N) expression.
(C,G,K,O) Embryos injected with Fgf8mo show
reduction in level and extent of dlx3 (C,G) and
pax2.1 (K,O) expression. (D,H,L,P) Embryos
injected with Fgf8mo and Fgf3mo together show
loss of dlx3 (D,H) and pax2.1 (L,P) expression.
Arrows indicate position of dlx3- and pax2.1-
expressing cells as appropriate.
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incubation with SU5402 (Fig. 6D-F), whereas mRNA was
detected in the hindbrain and adjacent presumptive otic
territory of control embryos at all stages (Fig. 6A-C). Thus,
bathing embryos in the inhibitor was sufficient to inhibit Fgfr
activity. Other embryos from the same experiment were
allowed to develop to the 16-somite stage and then analysed
for expression of pax2.1.
Embryos exposed to inhibitor between 30% epiboly and
tailbud and between 60% epiboly and 1- to 2-somite stages
showed absence of pax2.1 transcripts (compare Fig. 6G,H with
6J,K), whereas those incubated from 5-16 somites showed no
effect on expression (Fig. 6I,L; Table 2). These data indicate
that expression of early markers of the presumptive otic
territory is dependent upon Fgf signalling during a period
between 60% epiboly and tailbud stages; the period of co-
expression of fgf3 and fgf8 in the adjacent developing
hindbrain. 
An Fgf-independent event initiates the specification
of the otic ectoderm
We examined the requirement of Fgf3 and Fgf8 for the
induction of the earliest molecular marker of the presumptive
otic territory, pax8. In contrast to their effects on pax2.1 and
dlx3, neither Fgf3 nor Fgf8 morpholino injections reduced
either the apparent abundance or spatial extent of pax8
transcripts (Fig. 7A-C). Moreover, injection of both
morpholinos together reduced but did not abrogate pax8
expression (Fig. 7D; Table 1). To determine whether signalling
by another Fgf, acting either alone or in combination with Fgf3
and Fgf8, induces pax8, we examined expression following
treatment with SU5402. Embryos exposed to inhibitor between
either 30% epiboly and tailbud or 60% epiboly and 2-3 somites
still expressed abundant pax8 transcripts, although their spatial
extent along the anteroposterior axis was slightly reduced (Fig.
7E-H). Thus, we conclude that an Fgf-independent event
induces pax8 expression in the presumptive otic territory.
DISCUSSION
Fgf3 is required for otic development
Investigation of fgf3 expression in relation to otic development
in the zebrafish (this study) (Phillips et al., 2001) showed that
transcripts were detected within the prospective hindbrain
(90% epiboly) before the time of appearance of the first otic
markers (tailbud stage) (Pfeffer et al., 1998), consistent with
a role in regulating early otic development. As hindbrain
segmentation proceeded, fgf3 mRNA was confined to r4,
initially throughout that segment, but at later stages only
ventrally. This pattern of expression is similar to that reported
in Xenopus (Lombardo et al., 1998) but contrasts with the more
complex expression observed in this region of the mouse or
chick embryo head. In avian and mouse embryos, fgf3 is
dynamically expressed in posterior hindbrain segments,
initially in r4 but soon thereafter in r5 and r6, while becoming
downregulated in r4. Transcripts then become undetectable in
the bodies of each of these three rhombomeres but are detected
in the inter-rhombomeric boundary cells. By contrast, fgf3
expression was not found in zebrafish rhombomere boundary
cells. In addition, while fgf3 mRNA was never detected in
tissues adjacent to the hindbrain in zebrafish, it has been found
in ectoderm including the presumptive otic territory in both
Fig. 6. Loss of pax2.1 expression in embryos treated with an
inhibitor of Fgfr signalling. Embryos were treated with either DMSO
(A-C,G-I) or SU5402 (D-F,J-L) for 5 hours between 30% epiboly
and tailbud (A,D,G,J), 60% epiboly and 2-3 somite (B,E,H,K), or 5-
somite and 16-somite stages (C,F,I,L). Embryos were either fixed
immediately and hybridised for erm transcripts (A-F) or allowed to
develop until 16 somites and then hybridised for pax2.1 (G-L). (A-
F) erm transcripts are reduced or abrogated in the otic region and
hindbrain (brackets in A and D, arrows in B,C,E,F). (G-L) pax2.1
transcripts (arrows) are absent in embryos exposed to inhibitor at
early stages (G,H,J,K) but not at later stages (I,L).
Table 2. Effects of inhibition of Fgf signalling with SU5402
Gene Treatment Stage at treatment No effect Reduced expression Loss of expression
pax2.1 DMSO 30% epiboly 22/22 0/22 0/22
SU5402 30% epiboly 0/25 13/25 12/25
DMSO 60% epiboly 20/20 0/20 0/20
SU5402 60% epiboly 0/19 0/19 19/19
DMSO Five somites 12/12 0/12 0/12
SU5402 Five somites 47/47 0/47 0/47
pax8 DMSO 30% epiboly 20/20 0/20 0/20
SU5402 30% epiboly 37/37 0/37 0/37
DMSO 60% epiboly 32/32 0/32 0/32
SU5402 60% epiboly 37/37 0/37 0/37
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chick and mouse (Mahmood et al., 1995a; Mahmood et al.,
1996).
Comparison of the relationship of the fgf3 expression
domain in the hindbrain with those of pax2.1, pax8 or dlx3 in
adjacent ectoderm showed that Pax genes were expressed in a
region adjacent to rhombomeres 3 to 6. However, dlx3 was only
detected adjacent to rhombomeres 4 to 6. This more extensive
Pax-positive region has been reported by others in avian
embryos (Groves and Bronner-Fraser, 2000) and may represent
a region of competence to form otic placode, while the smaller
dlx3 domain may reflect a response to a signal that specifies
the otic primordium proper. Data on expression of erm, which
can be considered to be a direct indicator of cells receiving an
Fgf signal, indicates that cells throughout the Pax-positive
ectoderm are directly responding to Fgf (Raible and Brand,
2001).
Inhibition of Fgf3 in zebrafish embryos using morpholinos
produced a hypomorphic series as evinced by the variable
extent of Fgf protein loss and variability in severity of effects
on otic development. The most severely affected embryos
showed a reduction in otocyst size of about 30% and this
correlated with reductions in level and spatial extent of early
molecular markers of the otic placode. The reduction of
expression of early otic markers being indicative of an early
requirement for Fgf3 in otic placode development.
Embryos in which both Fgf3 and Fgf8 are inhibited
lack otic vesicles
The effects of Fgf3 knockdown on otocyst size were
remarkably similar to those observed in fgf8 mutant zebrafish
(Reifers et al., 1998) and the latter were reproduced by
injection of fgf8 morpholinos in this study. Taken together with
observations that fgf3 and fgf8 were co-expressed in the
presumptive r4 territory of the hindbrain adjacent to the region
in which the otic placode arises, this suggested that they might
function together during otic development. This was confirmed
in experiments in which morpholinos against both were co-
injected, resulting in complete loss of the otocyst in a
significant proportion of embryos and more severe reduction
of otocyst size in others compared with experiments using
single morpholinos. We interpret this range of phenotypes as
reflecting the generation of a hypomorphic series after
morpholino injections as has been reported by others
(Nasevicius and Ekker, 2000) and consistent with variation
between complete and partial loss of Fgf3 protein in individual
embryos. While this manuscript was in revision, similar
findings were reported by others after injection of Fgf3
morpholinos into ace mutant zebrafish embryos (Phillips et al.,
2001). However, Phillips et al. did not investigate specificity of
the Fgf3 morpholinos and did not demonstrate knockdown of
Fgf3 protein, the latter being important in interpreting
variability between injected embryos. In support of redundancy
in signalling to induce the otic vesicles, it is noteworthy that
mutant fish, which lacked otic vesicles, were not isolated from
mutagenesis screens (Whitfield et al., 1996).
Fgf3 and Fgf8 are required early during induction of
the otic placode
Loss of the otocyst in such embryos was presaged by absence
of early markers of otic placode; both pax2.1 and dlx3 were
not expressed in embryos injected with morpholinos against
both Fgfs. Injections of individual morpholinos resulted in
considerable reductions in both the spatial extent and relative
abundance of transcripts for both of these genes. This effect
correlates well with the reduced sizes of otic vesicles observed
in older embryos after such treatments and indicates that the
extent of the otic primordium may be determined by the level
of Fgf signal from the hindbrain. 
We examined both cell death and division in the ectoderm
at early stages of otic development in such embryos but found
no differences when compared with control embryos or those
injected with individual morpholinos. Taken together, our data
suggest that Fgf3 and Fgf8 are required at the earliest stages
of otic placode development. To confirm the requirement for
Fgf signalling and provide further data concerning when it is
required, we treated embryos at a range of developmental
stages with SU5402, a potent inhibitor of Fgfr activity.
Embryos treated between 30% epiboly and tailbud and
between 60% epiboly and 2-3 somites showed absence of
pax2.1 expression, whereas older embryos were unaffected.
This suggests that Fgf signalling is required only between 60%
epiboly and tailbud stages, correlating well with the onset of
fgf3 and fgf8 expression in the hindbrain.
Fgf3 and Fgf8 act directly on presumptive otic
ectoderm
A key question concerns whether or not these Fgfs act directly
upon presumptive otic ectoderm or indirectly via effects
mediated within the developing hindbrain. Certainly, loss of
Fgf3 and Fgf8 function has dramatic effects on the patterning
of the hindbrain, for example transcripts for valentino/
kreisler/mafb are not detected in such embryos (J. W., H. M.
and I. M., unpublished). However, evidence suggests that they
also act directly on adjacent ectoderm. First, absence of dlx3
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Fig. 7. Induction of pax8 in presumptive otic
ectoderm is independent of Fgf signals. (A-
D) pax8 transcripts are detected in control
embryos (A) and embryos injected with Fgf8
morpholino (B), Fgf3 morpholino (C), and Fgf3
and Fgf8 morpholinos together (D), and allowed
to develop to 2 somites. (E-H) Treatment with
SU5402 does not abolish pax8 expression.
(E,F) Embryos treated between 30% epiboly and
tailbud. (E) Control. (F) SU5402 treated.
(G,H) Embryos treated between 60% epiboly and
2-3 somites. (G) Control. (H) SU5402 treated.
Arrows indicate pax8 expression in presumptive
otic territory.
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transcripts occurs at tailbud stages, simultaneous with absence
of the earliest affected marker of hindbrain patterning,
valentino (Moens et al., 1996) (J. W., H. M. and I. M.,
unpublished). More importantly, expression of erm correlates
exactly with cells in which Erk1 and Erk2 have been activated
by Fgf signalling (Raible and Brand, 2001; Roehl and
Nusslein-Volhard, 2001). erm transcripts occupy a broad
domain within the zebrafish hindbrain at the time of fgf3 and
fgf8 signalling (Fig. 5A,B) (Raible and Brand, 2001; Roehl and
Nusslein-Volhard, 2001) but importantly this also includes the
pax2.1-positive ectoderm territory (Raible and Brand, 2001).
Taken together, these data indicate a direct action of hindbrain
Fgfs on presumptive otic ectoderm.
The dramatic effects of inhibition of both Fgf3 and Fgf8
together when compared with inhibition of either alone suggest
that they might perform redundant functions during otic
development. We have determined the receptor specificity of
mouse, Xenopus and zebrafish Fgf3 proteins, and in all cases
(Kiefer et al., 1993; Mathieu et al., 1995a; Mathieu et al.,
1995b; Kiefer et al., 1996b) Fgf3 binds and activates IIIb splice
variants of Fgf receptors, particularly of Fgfr2, whereas Fgf8
preferentially activates IIIc isoforms (Ornitz et al., 1996). Such
considerations suggest that each may signal through a different
Fgfr isoform and that redundancy may be at the level of
activation of intracellular signalling pathways.
Fgf signalling and otic development in other
vertebrate classes
Inhibition of Fgf3 function or its ectopic expression in chick
or mouse embryos has provided conflicting data concerning its
function(s) during otic development. Homozygous Fgf3 null
mice exhibit defects in endolymphatic duct formation but with
incomplete penetrance and expressivity (Mansour et al., 1992).
In addition, kreisler mouse mutants lack hindbrain Fgf3
expression but again have relatively mild otic defects (McKay
et al., 1996). Attempts to inhibit Fgf3 function in chick
embryos using antisense oligonucleotides affected otocyst
invagination but not placode induction (Represa et al., 1991),
while ectopic Fgf3 expression in cranial ectoderm resulted in
formation of small vesicular structures expressing some otic
markers (Vendrell et al., 2000). The relatively mild phenotypes
associated with Fgf3 inhibition are consistent with our finding
that Fgf8 must be inhibited with Fgf3 to prevent otic placode
formation.
Fgf8 expression has not been detected in the hindbrains of
chick or mouse embryos despite several detailed studies having
been undertaken (Heikinheimo et al., 1994; Ohuchi et al.,
1994; Crossley and Martin, 1995; Mahmood et al., 1995b) and
otic defects have not been reported in a murine Fgf8
hypomorphic series (Meyers et al., 1998). This raises the
possibility that another Fgf acts alongside Fgf3 in these
vertebrate classes, although low level expression of Fgf8
cannot be discounted. Interestingly, we have previously
reported Fgf4 transcripts in hindbrain neurectoderm at open
neural plate stages in the chick embryo (Shamim and Mason,
1999), where it is co-expressed with Fgf3 (Mahmood et al.,
1995a). At similar stages, Fgf4 is also co-expressed with
Fgf15/Fgf19 in mesoderm underlying the prospective otic
placode territory (Shamim et al., 1999; Ladher et al., 2000).
However, evaluation of the role(s) of both of these in vertebrate
otic development awaits appropriate inhibition studies.
The initial stage of otic induction is Fgf-independent
pax8 is currently the earliest molecular marker of the
presumptive otic territory (Pfeffer et al., 1998) and, in only one
embryo was its expression absent after injections of Fgf3 and
Fgf8 morpholinos. Both Fgf4 and Fgf15/Fgf19 are expressed
in mesoderm underlying the prospective otic territory in avian
embryos prior to the appearance of markers of otic induction.
Recent studies have suggested that Fgf15/Fgf19 might be a
mesodermal inducer for the otic placode (Ladher et al., 2000),
although its unique specificity for Fgfr4 (Xie et al., 1999) and
the lack of otic defects in Fgfr4-null mice (Weinstein et al.,
1998) indicate that it might not act alone. To further investigate
the potential role of other Fgfs, including those that are
mesodermally expressed, we examined embryos treated with
SU5402 from 30% epiboly for expression of pax8 transcripts
and failed to find any evidence of a requirement for Fgf
signalling in its induction. 
Ladher et al. (Ladher et al., 2000) also implicated Wnt8c,
which is expressed in the developing hindbrain, as a
component of the inductive cascade in avian embryos.
However, inhibition of retinoic acid signalling in the chick
embryo results in absence of Wnt8c but otic induction is
unaffected (Dupe and Lumsden, 2001), Thus, a different non-
Fgf signal is most probably involved in initiation of otic
induction. It is possible that this initiation signal is provided,
at least in part, by the cranial mesendoderm, as pax8 expression
is delayed in one-eyed pinhead zebrafish mutants, which lack
that tissue (Mendonsa and Riley, 1999; Phillips et al., 2001),
but is subsequently rescued possibly by neurectodermal Fgf
signalling.
We conclude that a non-Fgf signal(s), possibly of
mesendodermal origin, provides the first inductive cue in
specification of the otic ectoderm. Shortly thereafter, signalling
by Fgf3 and Fgf8 from the hindbrain induce the second phase
of gene expression within the latter territory further elaborating
its developmental programme. Inhibition of both Fgfs results
in a failure to execute that programme beyond its earliest
stages.
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